Related Experiment Video
Updated: Feb 25, 2026

10:15
Isolation and Culture Expansion of Tumor-specific Endothelial Cells
Published on: October 14, 2015
11.7K
Tumor endothelial cells accelerate tumor metastasis
1Vascular Biology, Frontier Research Unit, Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan.
Cancer Science
|August 2, 2017
Summary
Tumor endothelial cells secrete biglycan, a protein that promotes cancer metastasis. Understanding this interaction is key to controlling fatal cancer spread and improving patient outcomes.
Area of Science:
- Oncology
- Cancer Biology
- Molecular Mechanisms of Metastasis
Background:
- Tumor metastasis is the primary cause of cancer-related mortality.
- Tumor microenvironment interactions, including with stromal cells, drive cancer progression.
- Tumor angiogenesis is essential for tumor growth and provides routes for metastasis.
Purpose of the Study:
- To review the role of tumor stromal cells, particularly endothelial cells, in initiating tumor metastasis.
- To highlight the molecular mechanisms by which tumor endothelial cells influence tumor cell behavior.
Main Methods:
- Review of recent studies on tumor-endothelial cell interactions.
- Focus on angiocrine factors and cell-cell signaling pathways.
- Examination of the role of biglycan in promoting metastasis.
Main Results:
- Tumor endothelial cells exhibit altered phenotypes and release angiocrine factors.
- Bidirectional signaling between tumor and endothelial cells is critical for metastasis.
- Biglycan secreted by endothelial cells stimulates tumor cell metastasis.
Conclusions:
- Tumor endothelial cells play a significant role in the early stages of metastasis.
- Interactions involving biglycan represent a key mechanism driving cancer spread.
- Targeting endothelial cell-driven pathways may offer new therapeutic strategies against metastasis.
More Related Videos
Related Concept Videos
Metastasis
6.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.7K
The Tumor Microenvironment
8.0K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K
Adaptive Mechanisms in Cancer Cells
7.2K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K
Regulation of Angiogenesis and Blood Supply
3.8K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.8K
Tumor Progression
7.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.5K
Cancer
54.9K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
54.9K

